Cipher Pharmaceuticals (TSE:CPH – Get Free Report) (NASDAQ:CPHR) had its target price lifted by research analysts at Citigroup from C$4.75 to C$8.00 in a research note issued to investors on Wednesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective points to a potential upside of 12.68% from the […]
Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares trading hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % […]
Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares changing hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % The […]
Deciphera Pharmaceuticals, Inc. (DCPH) shares are surging more than 23 percent on Monday morning trade after the company announced improved revenue for the third quarter and positive results from its MOTION phase 3 study of Vimseltinib in patients with Tenosynovial giant cell tumor.
According to HCPH, the updated vaccine is free for those six months and older without health insurance or whose insurance does not cover all COVID-19 vaccine costs.